Revisiting cardiac injury during acute heart failure: further characterization and a possible target for therapy.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Cardiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amjcard.2014.09.040PMID 25456864
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.

  2013cited by this paper
• Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF

  2013cited by this paper
• Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

  2013cited by this paper
• Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.

  2013cited by this paper
• Long-term survival after hospitalization for acute heart failure--differences in prognosis of acutely decompensated chronic and new-onset acute heart failure.

  2013cited by this paper
• EURObservational Research Programme: regional differences and 1‐year follow‐up results of the Heart Failure Pilot Survey (ESC‐HF Pilot)

  2013cited by this paper
• Troponin I in acute decompensated heart failure: insights from the ASCEND‐HF study

  2012cited by this paper
• Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation

  2012cited by this paper
• Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section.

  2012cited by this paper
• Serial Measurement of Cardiac Troponin T Using a Highly Sensitive Assay in Patients With Chronic Heart Failure: Data From 2 Large Randomized Clinical Trials

  2012cited by this paper
• Impact of Serial Troponin Release on Outcomes in Patients With Acute Heart Failure: Analysis From the PROTECT Pilot Study

  2011cited by this paper
• Lessons learned from clinical trials in acute heart failure: phase 3 drug trials.

  2011cited by this paper
• A review of phase II acute heart failure syndromes clinical trials.

  2011cited by this paper
• Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)

  2011cited by this paper
• Soluble ST2, high‐sensitivity troponin T‐ and N‐terminal pro‐B‐type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure

  2011cited by this paper
• Troponin elevation in coronary vs. non-coronary disease.

  2011cited by this paper
• Serial changes in high‐sensitive troponin I predict outcome in patients with decompensated heart failure

  2011cited by this paper
• Troponin elevation in heart failure prevalence, mechanisms, and clinical implications.

  2010cited by this paper
• Release kinetics of intact and degraded troponin I and T after irreversible cell damage.

  2008cited by this paper
• Cardiac troponin and outcome in acute heart failure.

  2008cited by this paper
• Relation between cardiac troponin I and mortality in acute decompensated heart failure.

  2007cited by this paper
• Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure.

  2005cited by this paper
• The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF).

  2005cited by this paper
• Pathophysiologic targets in the early phase of acute heart failure syndromes.

  2005cited by this paper
• Ongoing Myocardial Injury in Stable Severe Heart Failure: Value of Cardiac Troponin T Monitoring for High-Risk Patient Identification

  2004cited by this paper
• Biochemical markers of myocyte injury in heart failure

  2004cited by this paper
• Preload Induces Troponin I Degradation Independently of Myocardial Ischemia

  2001cited by this paper
• Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

  1999cited by this paper
• Development of Short‐term Myocardial Hibernation Its Limitation by the Severity of Ischemia and Inotropic Stimulation

  1993cited by this paper

• Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial.

  2018cites this paper
• Clinical trials in acute heart failure: beginning of the end or end of the beginning?

  2017cites this paper
• The bumpy road to drug development for acute heart failure

  2016cites this paper